Guerbet
20.15
21-五月-25 08:29:59
15 分钟延时
股票
+0.21
+1.05%
今日范围
19.84 - 20.15
ISIN
FR0000032526
来源
Cboe
-
20 4月 2023 08:49:25 条件 Nasdaq GlobeNewswire
-
22 3月 2023 09:45:58 条件 Nasdaq GlobeNewswire
-
09 2月 2023 08:46:34 条件 Nasdaq GlobeNewswire
-
Guerbet: 2023 Strategic Priorities
16 1月 2023 09:40:42 条件 Nasdaq GlobeNewswire
-
11 1月 2023 10:46:47 条件 Nasdaq GlobeNewswire
-
Guerbet: Guerbet announces a change in governance for its Artificial Intelligence projects
03 11月 2022 10:04:18 条件 Nasdaq GlobeNewswire
-
Guerbet: Revenue at September 30, 2022
20 10月 2022 08:45:00 条件 Nasdaq GlobeNewswire
-
Guerbet announces U.S. Food and Drug Administration (FDA) approval of Elucirem™ (Gadopiclenol)
21 9月 2022 10:00:00 条件 Nasdaq GlobeNewswire
-
Guerbet: 2022 half-year results
21 9月 2022 08:45:00 条件 Nasdaq GlobeNewswire
-
Guerbet: Revenue at June 30, 2022
21 7月 2022 08:45:00 条件 Nasdaq GlobeNewswire
-
Guerbet receives EMA acceptance of EluciremTM as the Brand Name for Gadopiclenol
12 6月 2022 23:30:00 条件 Nasdaq GlobeNewswire
-
21 4月 2022 08:45:00 条件 Nasdaq GlobeNewswire
-
05 4月 2022 23:30:00 条件 Nasdaq GlobeNewswire
-
29 3月 2022 09:05:55 条件 Nasdaq GlobeNewswire
-
23 3月 2022 09:45:00 条件 Nasdaq GlobeNewswire
-
07 3月 2022 09:00:48 条件 Nasdaq GlobeNewswire
-
10 2月 2022 08:54:31 条件 Nasdaq GlobeNewswire
-
04 1月 2022 09:02:01 条件 Nasdaq GlobeNewswire
-
Guerbet and Bracco Imaging Announce a Global Strategic Collaboration Agreement for Gadopiclenol
13 12月 2021 22:00:00 条件 Nasdaq GlobeNewswire